Biological Products, (No Diagnostic Substances) · DE · CIK 1754068
Developing novel treatments for prevalent retinal diseases with unmet medical needs
Comparable business profile · signals at a glance
In the 90 days to Mar 20, 2026: 1 sold $13K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 20, 2026 | Hagen Brett RChief Accounting Officer | Sell | 1,915 | $6.72 | $13K |
| Dec 18, 2025 | Samsara Opportunity Fund, L.P.TenPercentOwner | Buy | 479,847 | $10.42 | $5.0M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.